Hallinan, Jazmine P.
Doyle, Lindsey A. http://orcid.org/0000-0002-0008-473X
Shen, Betty W.
Gewe, Mesfin M.
Takushi, Brittany
Kennedy, Madison A.
Friend, Della
Roberts, James M.
Bradley, Philip
Stoddard, Barry L. http://orcid.org/0000-0003-2250-9601
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01 GM139752, R01 GM123378)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Article History
Received: 5 April 2021
Accepted: 7 October 2021
First Online: 29 October 2021
Competing interests
: P.B. and B.L.S. are named inventors of the designed protein nanoparticles described in this work, which are described in IP filings by the Fred Hutchinson Cancer Research Center and are currently being licensed for commercialization. M.M.G. and J.M.R. are employees of Lumen Bioscience Inc., where studies of cTRP functionalization for potential commercial applications have been conducted. All other authors declare no competing interests.